Pharmacovigilance

The company has introduced a system for collecting messages from medical personal, patients, distributors as well as from other sources. The information about the development of adverse events or lack of efficacy is actively monitored.

The company has introduced a system for collecting messages from medical personal, patients, distributors as well as from other sources. The information about the development of adverse events or lack of efficacy is actively monitored.

By phone:

+7 (812) 660-06-10
+7 (812) 660-06-11

By post:

198320, St. Petersburg, Krasnoye Selo, st. Svobody, 52

On the website:


You can report manufacturer about any adverse events:

By phone:

+7 (903) 799-21-86, +374 94 540075 (Armenia)
+7 (499) 504-15-19, +375 29 895-15-88 (Belarus)
+7 (775) 439-20-61, +7 (777) 064-27-02 (Kazakhstan)
+996-999-015-045 (Kyrgyzstan)
+7 (499) 504-15-19, +7 (903) 799-21-86 (Tajikistan)
+998 90 928 29 99 (Uzbekistan)

By messengers:

+7 (903) 799-21-86

Go to website

For Latin America and the Caribbean

By phone:

+ 505 2299-2277

By post:

11098, Carretera Norte km 6, Managua, Nicaragua

Go to website